Werfen has signed a new long-term, exclusive partnership agreement with Thermo Fisher Scientific for worldwide distribution of TCAutomation laboratory automation system, in the specialized field of hemostasis diagnostics. Following their previous exclusive agreement, signed in 2015, this allows Werfen to continue offering HemoCell Specialized Lab Automation, with the largest installed base of hemostasis automation workcells globally, according to the company.
Related: Werfen Receives FDA Clearance for Hemostasis Testing System
HemoCell optimizes laboratory workflow, integrating all phases of testing. Comprised of Werfen’s ACL TOP Family 50 Series Hemostasis Testing Systems and HemoHub Intelligent Data Manager, with Thermo Fisher’s TCAutomation system, it standardizes sample processing, offering consistent turnaround times for routine and STAT samples. This allows increased walk-away time for laboratory staff, enhancing lab efficiency and quality. Ultimately, HemoCell helps improve the quality of care, while reducing costs.
“This significant continuation of our long-term distribution agreement is a testament to the strength of our partnership with Thermo Fisher Scientific,” says Remo Tazzi, vice president, Worldwide Marketing and Service, Hemostasis and Acute Care Diagnostics at Werfen. “It also speaks volumes about the success of HemoCell, and the quality of Werfen’s workflow experts, their innovative tools and processes, and the value they offer hospital laboratories around the world.”
The ACL TOP Family 50 Series hemostasis instrument family is designed to deliver efficiency, flexibility, and enhanced performance. The systems offer assay-specific pre-analytical sample integrity checks, advanced quality management, lab accreditation tools, and maximum flexibility with track sampling and front-loading. For routine to specialty testing in mid-to-high volume labs, each model in this standardized platform provides the same quality results, same intuitive software, and same features and usability.
HemoHub Intelligent Data Manager centralizes management of hemostasis testing and intelligent sample routing with real-time adaptations and queue balancing. It provides access to Werfen testing systems for operational performance, quality management, and clinical-decision support.
Featuring a comprehensive panel of fully automated hemostasis reagents, Werfen’s HemosIL assays include an extremely broad liquid, ready-to-use portfolio. From routine to specialty testing, HemosIL assays are standardized and automated for enhanced efficiency and optimal disease state management.
Designed to offer laboratories a truly efficient workflow through modularity, flexibility, and connectivity, the TCAutomation laboratory automation system helps manage the increasing workloads and improve quality. Offering flexible and cost-effective solutions, the most labor-intensive pre- and post- analytical tasks are automated. Its open concept supports direct interfaces to a wide range of analyzers. Easily expandable with additional modules, the TCAutomation system can help laboratories meet future needs and requirements, and increase efficiency, productivity, and safety.
